Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biliary Tract Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03772132
What this trial is testing

Chemothetapy FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

Who this might be right for
Cholangiocarcinoma of the Extrahepatic Bile DuctGallbladder Cancer
Shanghai Jiao Tong University School of Medicine 100
Testing effectiveness (Phase 2)Ended earlyNCT00868998
What this trial is testing

GTX Regimen for Biliary Cancers

Who this might be right for
Biliary Cancer
Columbia University 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT06465563
What this trial is testing

SHR-8068 in Combination With Adebrelimab, Bevacizumab, and Platinum-Based Chemotherapy as First-line Treatment in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 93
Not applicableUnknownNCT02189421
What this trial is testing

Multibending vs Conventional Endoscope for Direct Peroral Cholangioscopy

Who this might be right for
Common Bile Duct CalculiBiliary Tract CancerBiliary Stricture+1 more
Soonchunhyang University Hospital 110
Not applicableStudy completedNCT04484636
What this trial is testing

PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study)

Who this might be right for
Hepatocellular CancerCholangiocarcinomaGallbladder Cancer+3 more
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 400
Post-approval studies (Phase 4)Looking for participantsNCT05551299
What this trial is testing

Treatment of Non-resectable Bile Duct Cancer with Radiofrequency Ablation or Photodynamic Therapy

Who this might be right for
Hilar Cholangiocarcinoma
University of Leipzig 258
Testing effectiveness (Phase 2)Ended earlyNCT00955721
What this trial is testing

Combination of Gemcitabine, Oxaliplatin (GEMOX)-Sorafenib in Patients With Advanced Biliary Tract Cancer

Who this might be right for
CholangiocarcinomaBiliary Tract CancerGallbladder Cancer
University of Miami 9
Early research (Phase 1)Looking for participantsNCT06270706
What this trial is testing

PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumor
Pliant Therapeutics, Inc. 124
Testing effectiveness (Phase 2)Study completedNCT02558959
What this trial is testing

Second-line Irinotecan and Capecitabine Versus Irinotecan for Gemcitabine and Cisplatin Refractory Biliary Tract Cancer

Who this might be right for
Biliary Tract Neoplasms
Zhejiang University 64
Large-scale testing (Phase 3)Looking for participantsNCT07710885
What this trial is testing

Futibatinib (TAS-120) in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Taiho Pharmaceutical Co., Ltd. 784
Large-scale testing (Phase 3)Enrolling By InvitationNCT06671418
What this trial is testing

Primary Percutaneous Stenting Above the Ampulla Versus Endoscopic Drainage for Unresectable Malignant Hilar Biliary Obstruction

Who this might be right for
Cholangiocarcinoma Non-resectableGall Bladder CancerLiver Metastasis+1 more
Erasmus Medical Center 148
Not applicableStudy completedNCT07092397
What this trial is testing

Artificial Intelligence-based Tumor Microenvironment Analysis for Prognosis Prediction in Gallbladder Cancer

Who this might be right for
Gallbladder Cancer
Samsung Medical Center 266
Early research (Phase 1)Study completedNCT00654160
What this trial is testing

Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Anal CancerCarcinoma of the AppendixColorectal Cancer+9 more
Mayo Clinic 7
Not applicableStudy completedNCT07101874
What this trial is testing

Evaluate the Association of Biliary Complications and Treatment Duration in Unresectable BTC Patients

Who this might be right for
Biliary Tract Cancer
AstraZeneca 729
Early research (Phase 1)Study completedNCT01291615
What this trial is testing

Phase I Study of Gemcitabine or S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Kansai Hepatobiliary Oncology Group 6
Testing effectiveness (Phase 2)UnknownNCT03943043
What this trial is testing

Gemcitabine + Oxaliplatin +Nab-paclitaxel in Subjects With Advanced Biliary Tract Cancer

Who this might be right for
Cholangiocarcinoma
Istituto Clinico Humanitas 85
Testing effectiveness (Phase 2)Active Not RecruitingNCT04956640
What this trial is testing

Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)

Who this might be right for
Carcinoma, Non-Small-Cell LungColorectal NeoplasmsEndometrial Neoplasms+3 more
Eli Lilly and Company 540
Testing effectiveness (Phase 2)Active Not RecruitingNCT07635290
What this trial is testing

Anlotinib+Cadonilimab+PULSAR in Advanced Biliary Tract Cancer

Who this might be right for
Previously Treated, AdvancedBiliary Tract Cancers
West China Hospital 26
Testing effectiveness (Phase 2)UnknownNCT03609489
What this trial is testing

Investigate Apatinib Combined Capecitabine on Adjuvant Therapy of Biliary Carcinoma

Who this might be right for
Biliary Carcinoma
First Affiliated Hospital of Guangxi Medical University 40
Testing effectiveness (Phase 2)WithdrawnNCT04571710
What this trial is testing

A Trial of SHR1258 in Patients With Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Jiangsu HengRui Medicine Co., Ltd.
Next Page